JMP Securities Maintains Market Outperform Rating and Raises Price Target for Mirum Pharmaceuticals
Jonathan Wolleben, an analyst at JMP Securities, continues to show confidence in Mirum Pharmaceuticals (NASDAQ:MIRM) by maintaining a Market Outperform ...
